
Most patients in the UAE built their medical history somewhere else. None of it is in Malaffi, NABIDH or Riayati. Here is how clinics can capture it, make it usable and stop repeating tests that were already done.
Picture a new patient at a Dubai clinic. She moved from Mumbai two years ago, has type 2 diabetes, and brings a folder of laboratory reports, a discharge summary from a hospital at home and a list of the medicines she has taken for a decade. Her doctor wants to know how her HbA1c (glycated haemoglobin) has changed over time. The answer is in the folder, but not in any system the doctor can search.
This is an everyday situation in the UAE, where most residents are expatriates. Their medical histories were built in India, the Philippines, Pakistan, Egypt, the United Kingdom, South Africa and many other countries, in systems the UAE's exchanges have never seen.
In our first article on the UAE's health information exchanges, we looked at what providers need to get right for Malaffi, NABIDH and Riayati. This article looks at the history those exchanges cannot see, and at seven ways clinics and hospital groups can stop losing it.
Figure 1. Where a foreign history gets lost (top row), and the route that keeps it (bottom row).
Two developments in 2026 have made foreign records a practical issue rather than an inconvenience. Since February 2026, clinicians in Abu Dhabi have been required to use Malaffi before requesting any laboratory or radiology examination, so that unnecessary tests are not repeated.1 And in July 2026, after patients questioned tests that had already been done elsewhere, the Ministry of Health and Prevention stated that examinations must be medically justified.2
Both point in the same direction: clinicians should know what has already been done before they order more. For an expatriate patient, much of what has already been done happened abroad. The national record links more than 3,000 facilities,3 but none of them are in Manila or Johannesburg. Unless a clinic captures that history itself, the check comes up empty and the test is ordered again.
The best moment to capture a foreign history is the first visit, when the patient is in the room and motivated to share it. After that, the folder goes home and rarely comes back.
A simple intake routine makes a real difference. Ask every new patient, at booking, to bring previous reports. At the front desk, scan or photograph them, attach them to the correct patient record, and note the patient's consent for them to be used in their care. Ask the patient which documents matter most to them, and which conditions they are being treated for, so that the clinical team knows where to look first.
Ask yourself: Do our booking messages ask new patients to bring their previous reports, and does anyone at the front desk own what happens to them?
Laboratories around the world report the same tests in different units. Some countries report glucose and cholesterol in milligrams per decilitre, others in millimoles per litre. HbA1c can be reported as a percentage or in millimoles per mole. These differences are well understood, but in a busy clinic they are easy to miss, and a number read in the wrong unit can look normal when it is not.
Figure 2. The same result can look very different depending on where it was reported. Conversion factors from the NGSP master equation for HbA1c and a standard SI unit conversion table.
Reference ranges vary too, between countries and between laboratories, so a result flagged "normal" at home may not be read the same way in the UAE. When foreign results are structured, the original value, the original unit and the original reference range should all be kept, alongside any converted value, so a clinician can always see what the laboratory actually reported.
The same test can arrive under many names. A kidney function test may be listed under a laboratory's local abbreviation, a panel name or a long description. A thyroid test may appear as a single line or as part of a profile. Some reports group results in ways that make sense locally but not elsewhere.
Before foreign results can be trended alongside UAE results, each one needs to be matched to what it actually measures and mapped to medical coding standards. This is careful work: two tests with similar names can measure different things, and a confident but wrong match is worse than no match at all. Automated matching helps with scale, but it needs clinical review behind it.
Medication histories are often the most valuable part of a foreign record, and the hardest to use. Brand names differ from country to country, and even generic names can differ. The same medicine is called paracetamol in many countries and acetaminophen in others; salbutamol in some places is albuterol in others.6
Figure 3. Generic names alone can differ between countries, before brand names are even considered.
Mapping each foreign medicine to its active ingredient, strength and form lets a UAE clinician check for interactions, spot duplicated treatment and continue therapy safely. Where a brand cannot be matched with confidence, it should be flagged for a pharmacist or clinician rather than guessed.
Ask your team: When a patient's medicine list includes names we do not recognise, what happens today, and how long does it take?
A foreign result is only useful if the clinician knows how far to rely on it. That depends on who issued it, when the sample was taken, and how the laboratory works. Many laboratories are accredited to ISO 15189, the international standard for medical laboratories,7 and reports often say so.
When foreign records are structured, keep the issuing laboratory or hospital, its country, the date of the test (not just the date of the report) and any accreditation shown. Dates deserve particular care: day and month are written in different orders in different countries, and a misread date can make an old result look recent.
A scanned folder attached to a patient record is better than nothing, but it is not a history. It cannot be searched, trended or checked at the next visit without someone reading it again. The goal is for foreign results, diagnoses, procedures and medicines to sit in the same structured fields as UAE data, clearly labelled as coming from abroad.
Once they do, a clinician can see the patient's HbA1c over five years rather than five months, and can decide whether a new test is genuinely needed. That is exactly the judgement the new requirements expect. Whether and how outside history is shared onwards to Malaffi, NABIDH or Riayati depends on each exchange's rules, so confirm the position with your exchange team.
Figure 4. An illustrative HbA1c history. With foreign results structured and labelled, the clinician sees five years of progress instead of two visits.
Foreign records arrive from abroad, but once they are used in a patient's care in the UAE, the safest assumption is that they are UAE health data. Under Federal Law No. 2 of 2019, health data related to services provided in the UAE may not, by default, be stored, processed or transferred outside the country unless an exemption applies.8 Please confirm your own position with a legal adviser.
This matters because many tools now used to read documents, including large language models, process data outside the country by default. Before any tool or partner touches a patient's foreign records, ask where processing happens, where any reviewers access the data from, whether patient identifiers are needed at all, and how long anything is kept.
The exchanges are built around data from licensed UAE facilities. Whether outside history can be shared onwards depends on each exchange's rules, so check with your exchange team. What a clinic can always do is make that history usable in its own record.
Converted values make trending easier, but the original value, unit and reference range should always be kept so clinicians can see exactly what the laboratory reported.
Recording consent at intake is good practice and builds trust. Your specific obligations depend on your licence and setting, so confirm them with your regulator or legal adviser.
AI can extract and organise results at scale, but in healthcare it needs clinical review, an audit trail and attention to where data is processed. A confident wrong match on a test or a medicine is a patient safety issue.
An expatriate patient's history is one of the most useful things a UAE clinic can hold, and one of the easiest to lose. There are two ways we can help you keep it.
This article is for general information and is not legal or clinical advice.
Suhina Singh is a physician, the Founder and CEO of Jonda Health, and a health data strategist working at the intersection of artificial intelligence and clinical information systems.